News

Hims & Hers stands out for personalized, compounded medications and consistent margin expansion but faces rising risks tied ...
Semaglutide manufacturers seem to be taking advantage of America’s health crises to indulge in anticompetitive behavior.
Find insight on Innovent Biologics, Fisher & Paykel Healthcare and more in the latest Market Talks covering Health Care.
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Senate To Begin Marathon Vote Series On Trump's "Big, Beautiful Bill" As GOP Eyes July 4 Deadline The Senate is set to kick off what's expected to be a marathon session Monday, after the chamber ...